The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Open accessAbstract
PURPOSE: Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU). Classification of patients with influenza-associated pulmonary aspergillosis (IAPA) using the current definitions for invasive fungal diseases has proven difficult, and our aim was to develop case definitions for IAPA that can facilitate clinical studies. METHODS: A group of 29 international experts reviewed current insights into the epidemiology, diagnosis and management of IAPA and proposed a case definition of IAPA through a process of informal consensus. RESULTS: Since IAPA may develop in a wide range of hosts, an entry criterion was proposed and not host factors. The entry criterion was defined as a patient requiring ICU admission for respiratory distress with a positive influenza test temporally related to ICU admission. In addition, proven IAPA required histological evidence of invasive septate hyphae and mycological evidence for Aspergillus. Probable IAPA required the detection of galactomannan or positive Aspergillus culture in bronchoalveolar lavage (BAL) or serum with pulmonary infiltrates or a positive culture in upper respiratory samples with bronchoscopic evidence for tracheobronchitis or cavitating pulmonary infiltrates of recent onset. The IAPA case definitions may be useful to classify patients with COVID-19-associated pulmonary aspergillosis (CAPA), while awaiting further studies that provide more insight into the interaction between Aspergillus and the SARS-CoV-2-infected lung. CONCLUSION: A consensus case definition of IAPA is proposed, which will facilitate research into the epidemiology, diagnosis and management of this emerging acute and severe Aspergillus disease, and may be of use to study CAPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationDonnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
Self-citationSingle-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationInfluenza virus receptors in the human airway
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., & Kawaoka, Y. (2006) · Nature · doi:10.1038/440435a · Cited by 1,398
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Lescure, F.-X., Bouadma, L., Nguyen, D., Parisey, M., Wicky, P.-H., Behillil, S., Gaymard, A., Bouscambert-Duchamp, M., Donati, F., Le Hingrat, Q., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30200-0 · Cited by 1,092
Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887
Self-citationSchauwvlieghe, A. F. A. D., Rijnders, B. J. A., Philips, N., Verwijs, R., Vanderbeke, L., Van Tienen, C., Lagrou, K., Verweij, P. E., Van de Veerdonk, F. L., Gommers, D., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30274-1 · Cited by 886
Self-citationThe clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 795
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Blot, S. I., Taccone, F. S., Van den Abeele, A.-M., Bulpa, P., Meersseman, W., Brusselaers, N., Dimopoulos, G., Paiva, J. A., Misset, B., Rello, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-1978oc · Cited by 628
Self-citationTroeger, C. E., Blacker, B. F., Khalil, I. A., Zimsen, S. R. M., Albertson, S. B., Abate, D., Abdela, J., Adhikari, T. B., Aghayan, S. A., Agrawal, S., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30496-x · Cited by 576
COVID-19 Associated Pulmonary Aspergillosis
Koehler, P., Cornely, O. A., Böttiger, B. W., Dusse, F., Eichenauer, D. A., Fuchs, F., Hallek, M., Jung, N., Klein, F., Persigehl, T., et al. (2020) · Mycoses · doi:10.1111/myc.13096 · Cited by 547
Self-citationInfluenza virus-related critical illness: pathophysiology and epidemiology
Kalil, A. C., & Thomas, P. G. (2019) · Critical Care · doi:10.1186/s13054-019-2539-x · Cited by 524 · cited 1×
“1% of influenza patients require hospital admission with 5–10% of these requiring ICU admission [13, 14].”
BackgroundGalactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Self-citationBrüggemann, R. J. M., Alffenaar, J. C., Blijlevens, N. M. A., Billaud, E. M., Kosterink, J. G. W., Verweij, P. E., & Burger, D. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598327 · Cited by 457
Self-citationPrevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
Alanio, A., Dellière, S., Fodil, S., Bretagne, S., & Mégarbane, B. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30237-x · Cited by 457
Consensus Development Methods: A Review of Best Practice in Creating Clinical Guidelines
Black, N., Murphy, M., Lamping, D., McKee, M., Sanderson, C., Askham, J., & Marteau, T. (1999) · Journal of Health Services Research & Policy · doi:10.1177/135581969900400410 · Cited by 451
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy874 · Cited by 413
Park, W. B., Kim, N.-H., Kim, K.-H., Lee, S. H., Nam, W.-S., Yoon, S. H., Song, K.-H., Choe, P. G., Kim, N. J., Jang, I.-J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis599 · Cited by 399
Annane, D., Pastores, S. M., Rochwerg, B., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4919-5 · Cited by 371
Verweij, P. E., Ananda-Rajah, M., Andes, D., Arendrup, M. C., Brüggemann, R. J., Chowdhary, A., Cornely, O. A., Denning, D. W., Groll, A. H., Izumikawa, K., et al. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.001 · Cited by 330
Self-citationEarly-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
Ghez, D., Calleja, A., Protin, C., Baron, M., Ledoux, M.-P., Damaj, G., Dupont, M., Dreyfus, B., Ferrant, E., Herbaux, C., et al. (2018) · Blood · doi:10.1182/blood-2017-11-818286 · Cited by 307
Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
Dolton, M. J., Ray, J. E., Chen, S. C.-A., Ng, K., Pont, L. G., & McLachlan, A. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00626-12 · Cited by 290
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
van de Veerdonk, F. L., Netea, M. G., van Deuren, M., van der Meer, J. W., de Mast, Q., Brüggemann, R. J., & van der Hoeven, H. (2020) · eLife · doi:10.7554/elife.57555 · Cited by 284
Self-citationWauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., Lagrou, K., Wilmer, A., Jorens, P., & Hermans, G. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2673-2 · Cited by 265
Self-citationComplications of seasonal and pandemic influenza
Rothberg, M. B., & Haessler, S. D. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c92eeb · Cited by 236
Influenza-associated Aspergillosis in Critically Ill Patients
van de Veerdonk, F. L., Kolwijck, E., Lestrade, P. P. A., Hodiamont, C. J., Rijnders, B. J. A., van Paassen, J., Haas, P.-J., Oliveira dos Santos, C., Kampinga, G. A., Bergmans, D. C. J. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2540le · Cited by 230 · cited 3×
“Patients who survived IAPA received antifungal therapy much earlier than those who did not (2 days after diagnosis of influenza among survivors versus 9 days among non-survivors) [8], suggesting that early diagnosis and administration of antifungal therapy may be important.”
BackgroundResultSelf-citationTroke, P. F., Hockey, H. P., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01083-10 · Cited by 218
Increased incidence of co-infection in critically ill patients with influenza
Martin-Loeches, I., J Schultz, M., Vincent, J.-L., Alvarez-Lerma, F., Bos, L. D., Solé-Violán, J., Torres, A., & Rodriguez, A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4578-y · Cited by 216
Self-citationHage, C. A., Carmona, E. M., Epelbaum, O., Evans, S. E., Gabe, L. M., Haydour, Q., Knox, K. S., Kolls, J. K., Murad, M. H., Wengenack, N. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201906-1185st · Cited by 213
Martin-Loeches, I., Lisboa, T., Rhodes, A., Moreno, R. P., Silva, E., Sprung, C., Chiche, J. D., Barahona, D., Villabon, M., Balasini, C., et al. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2078-z · Cited by 210
Self-citationLansbury, L. E., Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Shen Lim, W. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004093 · Cited by 207 · cited 1×
“A recent Cochrane review on this topic concluded that the use of corticosteroids in patients with influenza was associated with a worse outcome [40].”
BackgroundPascual, A., Csajka, C., Buclin, T., Bolay, S., Bille, J., Calandra, T., & Marchetti, O. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis437 · Cited by 207
Self-citationTriazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management
Lestrade, P. P. A., Meis, J. F., Melchers, W. J. G., & Verweij, P. E. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.027 · Cited by 202
Self-citationTrifilio, S., Pennick, G., Pi, J., Zook, J., Golf, M., Kaniecki, K., Singhal, S., Williams, S., Winter, J., Tallman, M., et al. (2007) · Cancer · doi:10.1002/cncr.22568 · Cited by 199
A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients
Kumar, D., Ferreira, V. H., Blumberg, E. A., Silveira, F. P., Cordero, E., Pérez‐Romero, P., Aydillo, T., Danziger‐Isakov, L. A., Limaye, A. P., Carratalà, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy294 · Cited by 189
(ECIL), O. B. O. T. E. C. O. I. I. L., Maschmeyer, G., De Greef, J., Mellinghoff, S. C., Nosari, A., Thiebaut-Bertrand, A., Bergeron, A., Franquet, T., Blijlevens, N. M. A., & Maertens, J. A. (2019) · Leukemia · doi:10.1038/s41375-019-0388-x · Cited by 186
Self-citationFatal Aspergillosis in a Patient with SARS Who Was Treated with Corticosteroids
Wang, H., Ding, Y., Li, X., Yang, L., Zhang, W., & Kang, W. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307313490519 · Cited by 166
Vanderbeke, L., Spriet, I., Breynaert, C. M., Rijnders, B. J. A., Verweij, P. E., & Wauters, J. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000504 · Cited by 164
Self-citationBeumer, M. C., Koch, R. M., Beuningen, D. V., Oudelashof, A. M., van de Veerdonk, F. L., Kolwijck, E., van der Hoeven, J. G., Bergmans, D. C. J. J., & Hoedemaekers, C. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.11.013 · Cited by 150
Sun, K., & Metzger, D. W. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303049 · Cited by 130
Schwartz, I. S., Friedman, D. Z. P., Zapernick, L., Dingle, T. C., Lee, N. L. S., Sligl, W., Zelyas, N. J., & Smith, S. W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa007 · Cited by 111
Mulpuru, S., Li, L., Ye, L., Hatchette, T. F., Andrew, M. K., Ambrose, A., Boivin, G., Bowie, W., Chit, A., Santos, G. D., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.10.044 · Cited by 107
Ku, Y.-H., Chan, K., Yang, C.-C., Tan, C., Chuang, Y.-C., & Yu, W. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.06.002 · Cited by 87
Intensive care management of influenza-associated pulmonary aspergillosis
Koehler, P., Bassetti, M., Kochanek, M., Shimabukuro-Vornhagen, A., & Cornely, O. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.031 · Cited by 82
Self-citationInvasive Pulmonary Aspergillosis Associated With Influenza
Fischer, J. J., & Walker, D. H. (1979) · JAMA · doi:10.1001/jama.1979.03290400053024 · Cited by 80
The Corticosteroid Guideline Task Force of SCCM and ESICM, Pastores, S. M., Annane, D., & Rochwerg, B. N. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4951-5 · Cited by 78
Mercier, T., Dunbar, A., de Kort, E., Schauwvlieghe, A. F. A. D., Reynders, M., Guldentops, E., Blijlevens, N. M. A., Vonk, A. G., Rijnders, B. J. A., Verweij, P. E., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz079 · Cited by 75
Self-citationNeuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives
Bassetti, M., Castaldo, N., & Carnelutti, A. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1626824 · Cited by 70
Self-citationBoots, R. J., Paterson, D. L., Allworth, A. M., & FAOAGALI, J. L. (1999) · Thorax · doi:10.1136/thx.54.11.1047 · Cited by 68
Invasive aspergillosis in critically ill patients: An autopsy study
Tejerina, E. E., Abril, E., Padilla, R., Ruiz, C. R., Ballén-Barragán, A., Frutos–Vivar, F., Lorente, J. A., & Esteban, A. (2019) · Mycoses · doi:10.1111/myc.12927 · Cited by 66
Influenza-Associated Pulmonary Aspergillosis: A Local or Global Lethal Combination?
Rijnders, B. J. A., Schauwvlieghe, A. F. A. D., & Wauters, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa010 · Cited by 64
Self-citationRodríguez‐Góncer, I., Thomas, S., Foden, P., Richardson, M. D., Ashworth, A. D., Barker, J. M., Geraghty, C. G., Muldoon, E. G., & Felton, T. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3241-7 · Cited by 44
Siopi, M., Mavridou, E., Mouton, J. W., Verweij, P. E., Zerva, L., & Meletiadis, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku023 · Cited by 41
Self-citationThevissen, K., Jacobs, C., Holtappels, M., Toda, M., Verweij, P. E., & Wauters, J. (2020) · Critical Care · doi:10.1186/s13054-020-2808-8 · Cited by 40
Self-citationA Review of Antiviral and Antifungal Use and Safety during Pregnancy
Cottreau, J. M., & Barr, V. O. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1764 · Cited by 38
Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
Dewi, I. M. W., Cunha, C., Jaeger, M., Gresnigt, M. S., Gkountzinopoulou, M., Garishah, F. M., Duarte‐Oliveira, C., Campos, C. F., Vanderbeke, L., Reséndiz-Sharpe, A., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100289 · Cited by 34
Self-citationVehreschild, J. J., Bröckelmann, P. J., Bangard, C., Verheyen, J., Vehreschild, M. J. G. T., Michels, G., Wisplinghoff, H., & Cornely, O. A. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811002603 · Cited by 32
Self-citationHigh Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill COVID-19 Patients
Alanio, A., Dellière, S., Fodil, S., Bretagne, S., & Mégarbane, B. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3575581 · Cited by 27
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations
Muilwijk, E. W., Dekkers, B. G. J., Henriet, S., Verweij, P. E., Witjes, B. C. M., Lashof, A. M. L. O., Groeneveld, G. H., van der Hoeven, J., Alffenaar, J. C., Rüssel, F. G. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-17 · Cited by 26
Self-citationInfluenza Coinfection: Be(a)ware of Invasive Aspergillosis
Verweij, P. E., Brüggemann, R. J. M., Wauters, J., Rijnders, B. J. A., Chiller, T. M., & van de Veerdonk, F. L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz391 · Cited by 25
Self-citationSiopi, M., Mavridou, E., Mouton, J. W., Verweij, P. E., Zerva, L., & Meletiadis, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku484 · Cited by 6
Self-citation
Cited by
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S. C. A., Colombo, A. L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R. O., Vinh, D. C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30847-1 · Cited by 951
Self-citationUyeki, T. M., Hui, D. S., Zambon, M., Wentworth, D. E., & Monto, A. S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00982-5 · Cited by 560
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Bartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., Francalanci, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1065 · Cited by 473
Self-citationCOVID-19–associated Pulmonary Aspergillosis
van Arkel, A. L. E., Rijpstra, T. A., Belderbos, H. N. A., van Wijngaarden, P., Verweij, P. E., & Bentvelsen, R. G. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1038le · Cited by 370
Self-citation
Metadata
- Authors
- Verweij, P. E., Rijnders, B. J. A., Brüggemann, R. J. M., Azoulay, E., Bassetti, M., Blot, S., Calandra, T., Clancy, C. J., Cornely, O. A., Chiller, T., Depuydt, P., Giacobbe, D. R., Janssen, N. A. F., Kullberg, B.-J., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Liu, P. W.-L., Lortholary, O., Maertens, J., Martin-Loeches, I., Nguyen, M. H., Patterson, T. F., Rogers, T. R., Schouten, J. A., Spriet, I., Vanderbeke, L., Wauters, J., & van de Veerdonk, F. L.
- Venue
- Intensive Care Medicine
- Published
- 2020-06-22
- Volume
- 46
- Issue
- 8
- Pages
- 1524-1535
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W3036766665
- Cited by
- 459
- References
- 66
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.